|
21 Companies |
|
19 Products |
|
19 Products |
|
23 Mechanisms of Action |
|
0 Trials |
|
101 News |
|
| «123 |
- Xolair (omalizumab) / Roche, Novartis
Enrollment change: Efficacy and Safety of Omalizumab in Bullous Pemphigoid (clinicaltrials.gov) - Jan 10, 2012
P4, N=2, Completed, Sponsor: University of Iowa
N=12 --> 2
- Xolair (omalizumab) / Roche, Novartis
Trial completion: Efficacy and Safety of Omalizumab in Bullous Pemphigoid (clinicaltrials.gov) - Jan 10, 2012
P4, N=2, Completed, Sponsor: University of Iowa
N=12 --> 2 Recruiting --> Completed
- | New P4 trial, Surgery: Evaluation of Three Types of Dressings After Hip Surgery (clinicaltrials.gov) - Nov 3, 2011
P4, N=150, Completed, Sponsor: Hopital de l'Enfant-Jesus